Effects of neonatal lead exposure on memory in rats. 1981

K S Milar, and M R Krigman, and L D Grant

Five groups of rats exposed to varying doses of lead by gastric intubation from Day 3 to Day 30 of life were tested to determine whether lead affects memory. A variable intertrial interval spatial alternation task was used to examine memory; it permits generation of a complete retention curve within subjects in a single session. Because of lead's putative effects on the cholinergic neuronal system, the cholinergic drugs controls to the drugs and to compare drug effects with lead effects. Orderly memory functions were obtained in all animals; however lead-exposed groups did not differ in performance from controls. Scoopolamine decreased alternation accuracy but its effects did not differ across the neonatal dose groups.

UI MeSH Term Description Entries
D007854 Lead A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.
D007855 Lead Poisoning Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds. Poisoning, Lead,Lead Poisonings,Poisonings, Lead
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D012601 Scopolamine An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic. Hyoscine,Scopolamine Hydrobromide,Boro-Scopol,Isopto Hyoscine,Kwells,Scoburen,Scopace,Scopoderm TTS,Scopolamine Cooper,Transderm Scop,Transderm-V,Travacalm HO,Vorigeno,Boro Scopol,Transderm V

Related Publications

K S Milar, and M R Krigman, and L D Grant
January 1983, Neurobehavioral toxicology and teratology,
K S Milar, and M R Krigman, and L D Grant
January 1983, Neurobehavioral toxicology and teratology,
K S Milar, and M R Krigman, and L D Grant
October 1983, Nihon eiseigaku zasshi. Japanese journal of hygiene,
K S Milar, and M R Krigman, and L D Grant
September 1977, Toxicology and applied pharmacology,
K S Milar, and M R Krigman, and L D Grant
September 2017, Neurotoxicology,
K S Milar, and M R Krigman, and L D Grant
May 2022, Molecular neurobiology,
K S Milar, and M R Krigman, and L D Grant
July 2006, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases,
K S Milar, and M R Krigman, and L D Grant
May 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology,
K S Milar, and M R Krigman, and L D Grant
October 2008, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
K S Milar, and M R Krigman, and L D Grant
March 2005, Occupational and environmental medicine,
Copied contents to your clipboard!